Interim results for the HY ended 31 December 2023

Litigation Capital Management Ltd
19 March 2024
 

19 March 2024

 

Litigation Capital Management Limited

("LCM" or the "Company")

 

Interim results for the half year ended 31 December 2023

 

Highlights

 

Total realisations of A$28.4m, with concluded case investments generating a 3.3x multiple of cash invested

Realisations include performance fees of A$10.2m on concluded cases as the benefits of our fund management model are realised

Total income from litigation assets of A$21.9m, an increase from A$10.1m in HY23

Net Profit after tax for the period of A$7.3m, compared to a loss of A$2.3m in HY23

Net assets of A$185.4m as at 31 Dec 23 with cases conservatively valued at 2.0x cash invested

·

50% increase in applications for funding reflecting countercyclical nature of the business

Total new commitments of A$90m added in the period

Fund I which comprises US$150m of external capital is fully committed and Fund II which comprises US$291m of external capital is 35% committed at 29 Feb 24

·

A$3.36m1 share buy backs to 15 March 2024, 1.7m shares

 

Outlook

 

·

The Company is well positioned to take advantage of a sector that is rapidly gaining traction amidst consolidation amongst competitors

·

Expectation Fund II will be fully committed and Fund III launched within the next 12 months

 

(1 converted at 1.94 GBP to AUD)

 

Commenting on the results, Patrick Moloney, CEO of Litigation Capital Management, said: "These results demonstrate the opportunity that now presents itself for LCM. Having built a strong foundation for its fund management business, we are now seeing the benefits of it come to fruition. Fund I is already delivering strong returns, and we expect to fully commit Fund II as well as launch a new fund this year."

 

"At a time when demand for dispute finance is increasing, LCM is extremely well placed to take advantage of this opportunity. This set of results demonstrates that LCM has the knowledge and expertise to make sound investment decisions and deliver for shareholders and fund investors alike."

 

 

LCM will be hosting a webinar for investors today at 11.00 a.m. The presentation is open to all existing and potential shareholders. If you would like to attend this presentation, please register using the following link:

https://www.investormeetcompany.com/litigation-capital-management-limited/register-investor

 

A webinar presentation for analysts will take place at 9.30am. Analysts wishing to attend should contact lcm@tavistock.co.uk to register.

 

The accompanying results presentation is available on LCM's website: 

https://www.lcmfinance.com/investors/investor-presentations-results

 

The Interim Financial Report is available at:

https://www.lcmfinance.com/investors/investor-presentations-results 

 

Enquiries

 

Litigation Capital Management

c/o Tavistock PR 

Patrick Moloney, Chief Executive Officer

Mary Gangemi, Chief Financial Officer

 


 

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam




Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson


 


Tavistock PR

Tel: 020 7920 3150

Tim Pearson

Katie Hopkins

Simon Hudson

lcm@tavistock.co.uk

 

NOTES TO EDITORS

Litigation Capital Management (LCM) is an alternative asset manager specialising in disputes financing solutions internationally, which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is third party fund management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Portfolio funding and Acquisitions of claims. LCM generates its revenue from both its direct investments and also performance fees through asset management.

 

LCM has an unparalleled track record driven by disciplined project selection and robust risk management.

 

Currently headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

 



 

Chief Executive's Statement

 

Progress on Fund management business

 

2023 was the year in which our funds management business bedded down and for the first time showed the benefits, with Fund I investments generating cash and outsized returns. This has continued into the first half of the 2024 financial year, with the settlement of an Australian class action, part of Fund I, generating a ROIC after performance fees of 4.0 times.  Following the period end, as previously announced, LCM's investment related to a portfolio of two separate construction related disputes in Fund I has had a successful award, with the financial performance expected to be in line with our historic performance metrics.

 

The success of this model is clear to see, underpinned by the same rigorous underwriting process which LCM is known for and has developed, and we expect to see further case settlements from Fund I in the second half of the year.

 

Following on from Fund I, we expect Fund II to be fully committed within the next 12 months (commitments as at 31 December 2023 within Fund II: A$162m) and have plans to launch a further fund as well.

 

The Funds Management Model enables LCM to leverage third party capital and co-invest in a larger pool of diversified investments. Our co-investment in cases aligns LCM's interests with third party investors and enhances returns to LCM, through performance fees.

 

Building out this model has been one of our key goals, AUM has increased to A$561m at the end of the period (FY23: A$484m), putting us on solid foundations from which to expand and continue to deliver on this model to provide sustainable growth.

 

 

Investment performance

 

The performance of the business, following LCM's best ever year on record in FY 2023 remains strong. As we have reiterated previously, our investments do not generate linear returns, so the performance of the business in any given six or twelve month period may not accurately reflect the underlying performance of the business. On a three-year basis (FY22-24), our returns remain strong, with a rolling IRR of 67.4% and ROIC of 2.0 x. Recovery times have lengthened from a historic average of 30 months  over a 12.5 year period to 40 over the most recent three-year period, however we are hopeful that court delays as a result of the Covid pandemic, will continue to reduce.

 

Having moved to Fair Value accounting for FY23, investors can now get a clearer idea of the value of the portfolio, having previously valued all investments at cost. The value of all ongoing cases on our balance sheet was A$213m as at 31 Dec 23, valuing the cases at 2.0x cash invested compared to our long-term track record of achieving 2.8x cash invested. This demonstrates that despite the change in accounting methodology, we will continue to be prudent in our approach to valuation.

 

In the period, three cases concluded, generating A$28.4m of cash receipts for LCM, inclusive of $10.2m of performance fees with further recoveries due in H2. On these cases, a 3.3x multiple was achieved on A$8.7m cash invested.

 

Our underwriting team continue to see a strong pipeline of potential investments, with 242 applications for funding in the period, an increase of 50% on H1 2023. From these cases, we have so far committed A$90m to five cases, which again demonstrates our thorough due diligence and robust underwriting practices.

 

 

Outlook

 

LCM is well positioned to take advantage of the growing demands for disputes capital. Across our Asia, European and Australian operations, we have built out highly qualified teams of litigation finance professionals who have developed strong relationships in these markets. Across the globe, economic uncertainty and rising insolvencies means there is the expectation of an increase in disputes, which we believe will drive demand for LCM's capital. Alongside this, LCM finds itself in an improved competitive position, due to industry consolidation and in some cases contraction amongst existing litigation financiers.

 

Post year end, the UK Government has tabled legislation to end the uncertainty in litigation finance caused by the Supreme Court's ruling last July in PACCAR, which is a positive development for the industry.

 

We announced in the FY23 results that the business was exploring a sterling retail eligible bond listed on the ORB at the London Stock Exchange to optimise cost of capital and allow us to take advantage of opportunities we see in the market, as well as other alternative debt financing. These discussions are at an advanced stage and an update will be provided in due course.

 

 

 

Patrick Moloney

Chief Executive Officer

19 March 2024

 



 

Directors' Report

 

The Directors of Litigation Capital Management Limited (LCM) present their report together with the half-year financial report of the consolidated entity consisting of LCM and its subsidiaries (collectively LCM Group or the Group) for the six month period ended 31 December 2023 and the auditors' review report thereon.

1. Directors

The Directors of LCM at any time during or since the end of the financial period are set out below:

Jonathan Moulds

Patrick Moloney

Dr David King

Gerhard Seebacher

Mary Gangemi

 

2. Company Secretary

Anna Sandham was appointed Company Secretary of LCM in September 2016. Anna is an experienced company secretary and governance professional with over 20 years' experience in various large and small, public and private, listed and unlisted companies. Anna has previously worked for companies including AMP Financial Services, Westpac Banking Corporation, BT Financial Group and NRMA Limited. Anna holds a Bachelor of Economics (University of Sydney), Graduate Diploma of Applied Corporate Governance (Governance Institute of Australia) and is a Chartered Secretary.

3. Principal activities

LCM is a global provider of disputes finance and risk management services.

LCM has an unparalleled track record, driven by effective project selection, active project management and robust risk management. Headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

4. Operating and financial review

Overview of the LCM Group

LCM is a company limited by shares and was incorporated on 9 October 2015. LCM was admitted to trade on the Alternative Investment Market (AIM) of the London Stock Exchange on 19 December 2018 under the ticker LIT. LCM was formerly listed on the Australian Securities Exchange (ASX) between 13 December 2016 and 21 December 2018.

Its registered office and principal place of business is Level 12, The Chifley Tower, 2 Chifley Square, Sydney NSW 2000, Australia.

Operations

LCM operates its business through a series of wholly owned subsidiaries. The principal activity of those subsidiaries is the provision of litigation finance and risk management associated with individual and portfolios of disputes. LCM currently operates two business models.  The first is direct investments made from LCM's balance sheet capital.  The second is funds and/or asset management. Under those two business models, LCM currently pursues three investment strategies.  Those strategies are as follows:

Single‐case funding: The first and currently largest strategy, is single‐case funding.  That is, the investment in a single dispute.  This is a strategy that LCM has maintained since its inception (through its predecessor company) 25 years ago.  Currently, a large proportion of LCM's investments are in single‐case investments.

Portfolio funding: The second strategy pursued by LCM is portfolio funding.  That is, the provision of a portfolio based funding solution to law firms, insolvency practitioners or corporates.  It involves the provision of a financing solution and risk management tools for a bundle of separate disputes.  LCM's particular focus with respect to that strategy is the provision of corporate portfolio financing. 

Acquisitions of Claims: The third strategy, in its early stages of evolution, is the investment in smaller disputes (typically insolvency‐based) through the acquisition or assignment of the underlying cause of action. LCM generates its revenue through acquiring a cause of action and pursuing a recovery or award as principal.

 

Review of financial performance

The statutory profit for the Group after adjusting for income tax amounted to $7,293,000 (31 December 2022: loss $2,266,000). Adjusted profit before tax is $15,998,000 (31 December 2022: $1,324,000).

Cash on balance sheet was $87,701,000 as at 31 December 2023 (30 June 2023: $104,457,000). Of this, $17,450,000 relates to third-party cash which is restricted cash as it relates to balances held within the fund investment vehicles which have been consolidated with the Group numbers (30 June 2023: $21,484,000). Cash generated during the period from the resolution of investments was $72,772,000 (31 December 2022: $19,615,000).

The Directors do not recommend a dividend in respect of the period ended 31 December 2023.

5. Matters subsequent to the end of the financial period

In the Directors' opinion, no matter or circumstance has arisen since the end of the financial year, that has significantly affected, or may significantly affect, the operations of the Group, the results of those operations, or the state of affairs of the Group in future years.

6. Lead Auditor's independence declaration

The Auditor's independence declaration as required under section 307C of the Corporations Act 2001 is included in LCM's financial statements.

7. Rounding of amounts

LCM is of a kind referred to the Australian Securities and Investments Commission Corporations (Rounding in Financial/Directors' Reports) Instrument 2016/191, relating to 'rounding-off'. Amounts in this report have been rounded off in accordance with that Instrument to the nearest thousand dollars, or in certain cases, the nearest dollar.

 

 

Mr Jonathan Moulds

Chairman

19 March 2024

 



Consolidated statement of profit or loss and other comprehensive income

For the period ended 31 December 2023

 

 

 

 

Restated



31-Dec-23

31-Dec-22


Note

$'000

$'000

Income




Gain on financial assets at fair value through profit or loss

4

52,429

18,479

Movement in financial liabilities related to third-party interests in consolidated entities

4

(30,546)

(8,409)

Total income from litigation assets


21,883

10,070

Other income


-

-

Interest income


421

5

Expenses




Employee benefits expense

6

(5,938)

(4,759)

Depreciation expense

6

(80)

(80)

Corporate expenses


(1,960)

(2,708)

Finance costs

6

(5,543)

(3,876)

Fund administration expense

6

(1,474)

(1,139)

Foreign currency gains/(losses)


1,625

(1,316)

Total expenses


(13,369)

(13,878)

Profit/(loss) before income tax expense


8,935

(3,803)

Analysed as:


 

 

Adjusted operating profit


15,998

1,324

Non-operating expenses

6

(1,520)

(1,391)

Finance costs

6

(5,543)

(3,736)

Profit/(loss) before income tax expense


8,935

(3,803)

Income tax expense

7

(1,642)

1,537

Profit/(loss) after income tax expense


7,293

(2,266)

Other comprehensive income




Items that may be subsequently reclassified to profit and loss:




Movement in foreign currency translation reserve


(101)

310

Total comprehensive income for the period


7,192

(1,956)

Profit for the period is attributable to:




Owners of Litigation Capital Management Limited


7,293

(2,266)



7,293

(2,266)

Total comprehensive income for the period is attributable to:




Owners of Litigation Capital Management Limited


7,192

(1,956)



7,192

(1,956)

 

 

Cents

Cents

Basic earnings per share

21

6.84

(2.13)

Diluted earnings per share

21

6.37

(2.13)

 

Where applicable, comparative information has been restated to reflect a change in accounting for litigation funding agreements. Refer to Note 3.

 

The above Consolidated Statement of Profit or Loss and Other Comprehensive Income should be read in conjunction with accompanying Notes to the Financial Statements.

 

 

 

 

Consolidated statement of financial position

As at 31 December 2023

 



31-Dec-23

30-Jun-23


Note

$'000

$'000

 


 

 

Assets


 

 

Cash and cash equivalents

8

87,701

104,457

Trade & other receivables


1,838

2,209

Due from resolution of financial assets

9

19,430

11,873

Financial assets at fair value through profit or loss

10

391,011

391,410

Contract costs

11

39,377

37,277

Property, plant and equipment


182

211

Intangible assets


333

356

Other assets


1,180

1,110

Total assets


541,051

548,903

 




 




Liabilities




Trade and other payables

12

5,390

7,535

Tax payable


7,770

7,769

Employee benefits

13

988

906

Borrowings

14

59,783

68,976

Financial liabilities related to third-party interests in consolidated entities

15

244,726

243,990

Deferred tax liability

7

37,032

36,259

Total liabilities


355,689

365,435

Net assets

 

185,362

183,468





Equity




Issued Capital

16

69,674

69,674

Treasury shares

16

(796)

-

Reserves


1,404

1,042

Retained Earnings


115,080

112,753

Parent interest


185,362

183,468

Total equity


185,362

183,468

 

Where applicable, comparative information has been restated to reflect a change in accounting for litigation funding agreements. Refer to Note 3.

 

The above Consolidated Statement of Financial Position should be read in conjunction with accompanying Notes to the Financial Statements

Consolidated statement of changes in equity

For the period ended 31 December 2023

 





Share based

Foreign

 


Issued

Treasury

Retained

payments

currency

Total

 

capital

shares

earnings

reserve

translation

equity

Consolidated

$'000

$'000

$'000

$'000

$'000

$'000

Balance at 1 July 2022 (restated)

69,674

-

81,268

1,573

(3,585)

148,929

Loss after income tax expense for the period

-

-

(2,266)

-

-

(2,266)

Other comprehensive income for the period

-

-

-

-

310

310

Total comprehensive income for the period

-

-

(2,266)

-

310

(1,956)

Equity Transactions:

 






Share-based payments (note 22)

-

-

-

308

-

308


-

-

-

308

-

308

Balance at 31 December 2022 (restated)

69,674

-

79,002

1,881

(3,275)

147,281





Share based

Foreign

 


Issued

Treasury

Retained

payments

currency

Total

 

capital

shares

earnings

reserve

translation

equity

Consolidated

$'000

$'000

$'000

$'000

$'000

$'000

Balance at 1 July 2023

69,674

-

112,753

2,440

(1,398)

183,468

Profit after income tax expense for the period

-

-

7,293

-

-

7,293

Other comprehensive income for the period

-

-

-

-

(101)

(101)

Total comprehensive income for the period

-

-

7,293

-

(101)

7,193

Equity Transactions:

 






Share-based payments (note 22)

-

-

-

463

-

463

Dividends paid (note 17)

-

-

(4,966)

-

-

(4,966)

Treasury shares acquired (note 16)

-

(796)

-

-

-

(796)


-

(796)

(4,966)

463

-

(5,298)

Balance at 31 December 2023

69,674

(796)

115,080

2,903

(1,498)

185,362

 

Where applicable, comparative information has been restated to reflect a change in accounting for litigation funding agreements. Refer to Note 3.

 

The above Consolidated Statement of Changes in Equity should be read in conjunction with accompanying Notes to the Financial Statements.

 

Consolidated statement of cash flows

For the period ended 31 December 2023

 

 


 

Restated

 


31-Dec-23

31-Dec-22


Note

$'000

$'000

Cash flows from operating activities




Profit/(loss) after income tax expense for the period


7,293

(2,266)

Adjustments for:




Gain on financial assets at fair value through profit or loss


(21,586)

(7,140)

Depreciation and amortisation of intangibles


80

80

Share-based payments


463

308

Finance costs reclassified to financing activities


5,543

3,904

Income tax expense


1,642

(1,537)

Exceptional items


(144)

(39)

Fund costs reclassified to financing activities


991

777

Other, including foreign exchange rate movements


(1,122)

(5,887)





Change in operating assets and liabilities:




Proceeds from resolution of financial assets

9

72,164

21,804

Decrease/(increase) in trade and other receivables


608

(2,189)

(Funding) of financial assets

10

(31,531)

(50,099)

(Increase) in contract costs - litigation contracts


(2,305)

(2,938)

Decrease/(increase) in financial assets


780

432

(Decrease)/Increase in trade and other payables


(2,145)

59

(Decrease)/Increase in employee benefits


81

(22)

Income Tax paid


(868)

-

(Increase) in other assets


(161)

604

Net cash from/(used in) operating activities


29,785

(44,149)

Cash flows from investing activities




Payments for property, plant and equipment


(13)

(22)

Payments for intangibles


(15)

(34)

Refund/(payment) of security deposits


13

(12)

Net cash used in investing activities


(15)

(69)

Cash flows from financing activities




Payments for treasury shares


(796)

-

Dividends paid

17

(4,966)

-

Repayments of borrowings

14

(8,139)

(14,494)

Payments of finance costs


(5,752)

(3,482)

Payments of fund costs related to third-party interests


(991)

(777)

Contributions from third-party interests in consolidated entities

15

11,010

45,298

Distributions to third-party interests in consolidated entities

15

(35,717)

-

Net cash (used in)/from financing activities


(45,351)

26,545

Net increase/(decrease) in cash and cash equivalents


(15,581)

(17,673)

Cash and cash equivalents at the beginning of the period


104,457

49,964

Effects of exchange rate changes on cash and cash equivalents


(1,175)

1,108

Cash and cash equivalents at the end of the period

8

87,701

33,399

 

Where applicable, comparative information has been restated to reflect a change in accounting for litigation funding agreements. Refer to Note 3.

 

The above Consolidated Statement of Financial Position should be read in conjunction with accompanying Notes to the Financial Statements

Notes to the financial statements

For the period ended 31 December 2023

 

Note 1 General Information

 

The financial statements cover Litigation Capital Management Limited (the 'Company') as a Group consisting of Litigation Capital Management Limited and the entities it controlled at the end of, or during, the period (referred to as the 'Group'). The financial statements are presented in Australian dollars, which is Litigation Capital Management Limited's functional and presentation currency.

 

Litigation Capital Management Limited was admitted onto the Alternative Investment Market ('AIM') on 19 December 2018.

 

Litigation Capital Management Limited is a listed public company limited by shares, incorporated and domiciled in Australia. Its registered office and principal place of business is:

 

Level 12, The Chifley Tower

2 Chifley Square

Sydney NSW 2000

 

A description of the nature of the Group's operations and its principal activities are included in the Directors' report, which is not part of the financial statements.

 

The financial statements were authorised for issue, in accordance with a resolution of Directors, on 19 March 2024. The Directors have the power to amend and reissue the financial statements.

 

Note 2 Significant accounting policies

These consolidated financial statements are general purpose financial statements for the interim reporting period ended 31 December 2023 and have been prepared in accordance with the Corporations Act 2001 and Australian Accounting Standard AASB 134 Interim Financial Reporting. Compliance with AASB 134 ensures compliance with International Financial Reporting Standard IAS 34 'Interim Financial Reporting'.

 

These interim financial statements do not include all the notes of the type normally included in annual financial statements. Accordingly, these financial statements are to be read in conjunction with the annual report for the year ended 30 June 2023 and any public announcements made by the Company during the interim reporting period.

 

Basis of preparation

The principal accounting policies adopted are consistent with those of the previous financial year and corresponding interim reporting period, unless otherwise stated.

 

New or amended Accounting Standards and Interpretations adopted

The consolidated entity has adopted all of the new or amended Accounting Standards and Interpretations issued by the Australian Accounting Standards Board ('AASB') that are mandatory for the current period.

 

Any new or amended Accounting Standards or Interpretations that are not yet mandatory have not been early adopted.

 

Historical cost convention

The financial statements have been prepared under the historical cost convention.

 

Critical accounting estimates

The critical accounting judgements, estimates and assumptions that have been applied in the preparation of the interim consolidated financial statements are consistent with those followed in the preparation of the Group's annual report for the year ended 30 June 2023.

 

Operating segments

Operating segments are presented using the 'management approach', where the information presented is on the same basis as the internal reports provided to the Chief Operating Decision Makers ('CODM'). The CODM is responsible for the allocation of resources to operating segments and assessing their performance.

 

Note 3 Restatement of comparative

 

As disclosed in the 30 June 2023 Annual Report, the Group reassessed its classification of the funding of its litigation funding agreements, which resulted in the majority of the Group's litigation funding assets now being recognised under AASB 9. Under this change, litigation funding agreements and third-party interest in consolidated entities are accounted for as financial instruments under AASB 9 Financial Instruments.

 

As a result of implementing this accounting for litigation funding agreements for relevant contracts, the Group has restated the Consolidated statement of profit or loss and other comprehensive income for the period ended 31 December 2022 for comparative purposes.

 

The restatement of each of the affected financial statement line items for the prior periods, as follows:

 

Impact on consolidated statement of profit and loss and other comprehensive income (increase/(decrease) in profit)

 


31-Dec-23


$'000

Income

 

Litigation service revenue

(4,699)

Litigation service expense

3,558

Net gains/(losses) on financial assets at fair value through profit or loss

18,479

Movement in financial liabilities related to third-party interests in consolidated entities

(8,409)

Total expenses

(1,801)

Income tax expense

(1,897)

Net impact on profit for the period

7,128

Attributable to:


Equity holders of the parent

7,128

Other comprehensive income

1,583

Net impact on total comprehensive income for the period

8,711

 

Impact on basic and diluted earnings per share (EPS) (increase/(decrease) in EPS)

 

Earnings per share

Cents

Basic, profit for the period attributable to ordinary equity holders of the parent

4.90

Diluted, profit for the period attributable to ordinary equity holders of the parent

4.90

 

Consolidated statement of cashflows

The change did not have a net impact on the Group's operating, investing and financing cash flows but did require some change to components within each cash flow class.

 

Note 4 Income

 


 

Restated


31-Dec-23

31-Dec-22


$'000

$'000

Realised gains on litigation assets

10,866

(34)

Realised performance fees

8,776

-

Fair value adjustment during the period, net of previously recognised unrealised gains transferred to realised gains

2,381

6,168

Foreign exchange gains

(437)

1,006

Total income from litigation assets attributable to LCM

21,586

7,140

Gain on financial assets related to third-party interests in consolidated entities

30,843

11,339


52,429

18,479

Loss on financial liabilities related to third-party interests in consolidated entities

(30,546)

(8,409)

Total income from litigation assets

21,883

10,070

 

Total income from litigation assets attributable to LCM represents realised and unrealised gains that relate to LCM's funded proportion of litigation contracts. The gain and loss related to third party interests in consolidated entities represents realised and unrealised gains and losses that relate to third party funded proportions  from LCM controlled entities. Realised gains relate to amounts where litigation risk has concluded and amounts are expected to be received by LCM. Unrealised gains or losses relate to the fair value movement of assets and liabilities associated with litigation contracts.

 

Note 5 Segment Information

 

The Group's operating segments are based on the internal reports that are reviewed and used by the Board of Directors (who are identified as the Chief Operating Decision Makers ('CODM')) in assessing performance and in determining the allocation of resources.

 

The Directors have determined that there is one operating segment. The information reported to the CODM is the consolidated results of the Group. The segment result is as shown in the statement of profit or loss and other comprehensive income. Refer to statement of financial position for assets and liabilities.

 

Note 6 Profit before tax

 



Restated

 

31-Dec-23

31-Dec-22

 

$'000

$'000

Profit before income tax expense includes the following specific expenses:



Employee benefits expense

 


Salaries & wages

4,530

3,841

Directors' fees

228

196

Superannuation and pension

147

138

Share based payments expense

463

308

Other employee benefits & costs

570

276


5,938

4,759

Depreciation

 


Plant and equipment

42

20

Intangible assets

38

60


80

80

Interest on borrowings (note 14)

5,340

3,536

Finance costs of third-party interests

-

140

Other finance costs

202

200


5,543

3,876

Fund administration expense

 


General administration expenses

483

289

Set-up expenses

-

73

Placement fees

991

777


1,474

1,139

Leases

 


Short-term lease payments

451

379

 

Adjusted operating profit

 

Adjusted operating profit excludes non-operating expenses which includes items which are considered unusual, non-cash or one-off in nature.

 

Non-operating expenses

Management have opted to separately present these items as it better reflects the Groups underlying performance. Non-operating expenses includes the following items:

 

Share based payments expense

463

308

Other transaction costs

15

38

Litigation fees

-

225

Other expenses

51

42

Fund administration expenses

991

777

Total non-operating expenses

1,520

1,391

 

Note 7 Income tax expense

 




Restated

 


31-Dec-23

31-Dec-22

 


$'000

$'000

Numerical reconciliation of income tax expense and tax at the statutory rate

 



Profit before income tax expense


8,935

(3,803)





At the Group's statutory income tax rate of 25% (2022: 25%)


2,234

(951)





Tax effect amounts which are not deductible/(taxable) in calculating taxable income:





Foreign tax rate adjustments

(24)

(33)


Share-based payments

116

77


Change in tax rate

(684)

(630)

Income tax expense / (benefit)


1,642

(1,537)

 

Statutory tax rate of 25% is applicable to Australian entities with aggregated turnover below $50 million for the period ended 31 December 2023. The Group's turnover is expected to be above the threshold of $50 million in the future reporting periods which will attract a statutory tax rate of 30%. As a result, recognition of deferred tax asset is made by applying a 30% statutory rate instead of the lower 25% tax rate.

 

Note 8 Cash and cash equivalents

 


31-Dec-23

30-Jun-23


$'000

$'000

Cash at Bank

30,121

82,973

Investment securities held for liquidity purposes

40,130

-

Cash of third-party interests in consolidated entities

17,450

21,484


87,701

104,457

Cash of third-party interests in consolidated entities is restricted as it is held within the fund investment vehicles on behalf of the third-party investors in these vehicles. The cash is restricted to use cashflows in the litigation funding assets made on their behalf and costs of administering the fund.

 

Note 9 Due from resolution of financial assets

 


31-Dec-23

30-Jun-23


$'000

$'000

At start of period (as restated as at 1 July 2022)

11,873

24,340

Transfer from realisation of litigation funding assets

77,891

150,447

Proceeds from litigation funding assets

(72,164)

(192,623)

Foreign Exchange gain/(losses)

1,830

29,708

Balance as at end of period

19,430

11,873

 

Note 10  Litigation Funding assets at fair value through profit or loss

 


31-Dec-23

30-Jun-23


$'000

$'000

At start of period (as restated as at 1 July 2022)

391,410

296,980

Deployments

15,187

30,756

Deployments - third-party interests

16,345

58,293

Realisations of litigation funding assets

(77,891)

(150,447)

Income for the period

52,429

136,638

Foreign exchange gains/(losses)

(6,469)

19,191

Balance as at end of period

391,011

391,410

Litigation funding assets at fair value through income statement

173,766

165,768

Litigation funding assets at fair value through income statement - third-party interests

217,245

225,642

Total litigation funding assets

391,011

391,410

 

Litigation Funding assets are financial instruments that relate to the provision of capital in connection with legal finance. The Group fund through both direct investments as well as using third party funders via a Fund model. The table above sets forth the changes in LFA assets at the beginning and end of the relevant reporting periods.

 

Note 11 Contract costs - litigation contracts

 

 

 

31-Dec-23

30-Jun-23


 

$'000

$'000

Contract costs - litigation contracts


39,377

37,277

 

There are a small number of legacy investments which are still being recorded under AASB 15 Revenue from Contract with Customers due to the timing the contracts were entered into. These are expected to resolve in the short to medium term.

 

Reconciliation of litigation contract costs

Reconciliation of the contract costs at the beginning and end of the current period and previous financial year are set out below:

 

 

 

 

31-Dec-23

30-Jun-23


 

$'000

$'000

Balance at 1 July

 

37,277

31,783

Additions during the period

 

2,305

5,495

Realisations of contract assets

 

(206)

-

Balance as at end of period

 

39,377

37,277


 

 

 

 

 

The Group has recognised impairment losses of $nil (2022: $nil) in profit or loss on contract costs for the period ended 31 December 2023.

 

Note 12 Trade and other payables

 

 

 

 

31-Dec-23

30-Jun-23


 

$'000

$'000

Trade payables

 

4,976

7,001

Other payables

 

414

534


 

5,390

7,535

 

 

Note 13 Employee benefits

 

 

 

31-Dec-23

30-Jun-23


 

$'000

$'000

Annual Leave

 

654

623

Long Service Leave

 

334

283


 

988

906

 

Note 14 Borrowings

 

 

 

 

31-Dec-23

30-Jun-23


 

$'000

$'000

Borrowings

 

59,783

68,976


 

59,783

68,976

 

 

 

Reconciliation of borrowings of third-party interests in consolidated entities:

31-Dec-23

30-Jun-23


$'000

$'000

Balance 1 July

-

14,494

Repayment of borrowings

-

(14,848)

Net accrued interest

-

(17)

Amortisation of borrowing costs

-

34

Other non-cash items

-

336

Balance as at end of period

-

-




Reconciliation of borrowings of LCM:

31-Dec-23

30-Jun-23


$'000

$'000

Balance 1 July

68,976

54,915

Proceeds from borrowings

-

9,636

Repayment of borrowings

(8,139)

-

Payments for borrowing costs

(58)

(256)

Net accrued interest

(713)

-

Amortisation

764

2,441

Other non-cash items

(1,047)

2,241

Balance as at end of period

59,783

68,976

 

On 22 February 2021, LCM entered into a credit facility with Northleaf Capital Partners for an aggregate amount of US$50,000,000, AUD equivalent of $75,017,5171 (the "Facility"). The Facility carries interest together with a profit participation, capped at 13% per annum. The Facility has an overall term of four years and is secured against LCM's assets. As at 31 December 2023, LCM has nil outstanding utilisation. Borrowings have a maturity date of February 2025.

 

LCM agreed to various debt covenants including a minimum effective net tangible worth, borrowings as a percentage of effective net tangible worth, minimum liquidity, a minimum consolidated EBIT and a minimum multiple of invested capital on concluded contract assets over a specified period. There have been no defaults or breaches related to the Facility during the year ended 31 December 2023. Should LCM not satisfy any of these covenants, the outstanding balance of the Facility may become due and payable.

 

LCM incurred costs in relation to arranging the Facility of $1,649,000 which were reflected transactions costs and will be amortised over the 4 year term of the borrowings. As at 31 December 2023, $622,000 of the loan arrangement fees remained outstanding.

 

1 Converted at the functional currency spot rates of exchange at the reporting date

 

Note 15 Financial liabilities related to third-party interests in consolidated entities

 


31-Dec-23

30-Jun-23


$'000

$'000

Balance 1 July

(243,990)

(142,180)

Proceeds - capital contributions from Limited Partners

(11,010)

(74,980)

Payments - distributions to Limited Partners

35,717

94,373

Loss on financial liabilities related to third-party interests in consolidated entities (note 4)

(30,546)

(111,953)

Other non-cash items, including foreign exchange gain/loss

5,104

(9,250)

Balance as at end of period

(244,726)

(243,990)

 

Note 16 Equity - issued capital

 


31-Dec-23

30-Jun-23

31-Dec-23

30-Jun-23


Shares

Shares

$'000

$'000

Ordinary shares - fully paid

106,445,388

106,613,927

69,674

69,674

Ordinary shares - under loan share plan

12,331,148

12,586,405

-

-


118,776,536

119,200,332

69,674

69,674






Movements in ordinary share capital


Date

Shares

$'000

Balance


30 June 2022

106,613,927

69,674

Balance


30 June 2023

106,613,927

69,674

Options exercised


31 October 2023

87,993

-

Options exercised


23 November 2023

167,264

-

Shares bought back during the period


Various

(423,796)

-



31 December 2023

106,445,388

69,674

 

As announced on 5 October 2023, the Group commenced a share buyback programme in respect of its ordinary shares up to a maximum consideration of A$10.0 million from the date of this announcement.

 

Movements in ordinary shares issued under loan share plan ('LSP'):


Date

Shares

$'000

Balance


30 June 2022

12,586,405

-

Balance


30 June 2023

12,586,405

-

Options exercised


31 October 2023

(87,993)

-

Options exercised


23 November 2023

(167,264)

-



31 December 2023

12,331,148

-

 

Reconciliation of ordinary shares issued under LSP:


 

31-Dec-23

30-Jun-23

Total shares allocated under existing LSP arrangements with underlying LSP shares (note 22)



7,890,408

7,890,408

Less shares allocated under existing LSP arrangements without underlying LSP shares (note 22)



(221,467)

(221,467)

Shares held by LCM Employee Benefit Trust for future allocation under employee share and option plans

 


4,917,464

4,917,464

Exercise of options during the period held by the LCM Employee Benefit Trust

 


(255,257)

-




12,331,148

12,586,405

 

Ordinary shares

Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the Company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have no par value and the Company does not have a limited amount of authorised capital.

 

On a show of hands every member present at a meeting in person or by proxy shall have one vote and upon a poll each share shall have one vote.

 

Ordinary shares - under loan share plan ('LSP')

The Company has an equity scheme pursuant to which certain employees may access a LSP. The acquisition of shares under this LSP is fully funded by the Company through the granting of a limited recourse loan. The shares under LSP are restricted until the loan is repaid. The underlying options within the LSP have been accounted for as a share-based payment. Refer to note 22 for further details. When the loans are settled the shares are reclassified as fully paid ordinary shares and the equity will increase by the amount of the loan repaid.

 

Ordinary shares - partly paid

As at 31 December 2023, there are currently 1,433,022 partly paid shares issued at an issue price of $0.17 per share. No amount has been paid up and the shares will become fully paid upon payment to the Company of $0.17 per share. As per the terms of issue, the partly paid shares have no maturity date and the amount is payable at the option of the holder.

 

Partly paid shares entitle the holder to participate in dividends and the proceeds of the Company in proportion to the number of and amounts paid on the shares held. The partly paid shares do not carry the right to participate in new issues of securities. Partly paid shareholders are entitled to receive notice of any meetings of shareholders. The partly paid shareholders are entitled to vote in the same proportion as the amounts paid on the partly paid shares bears to the total amount paid and payable.

 

Treasury shares

As at 31 December 2023, there were 423,796 treasury shares (December 2022: nil). Treasury shares comprises shares bought back from shareholders which are held by Canaccord on behalf of the Company and classified as treasury shares.

 

Capital risk management

The Group's objectives when managing capital is to safeguard its ability to continue as a going concern, so that it can provide returns for shareholders and benefits for other stakeholders and to maintain an optimum capital structure to reduce the cost of capital.

 

Capital is regarded as total equity as recognised in the statement of financial position.

 

In order to maintain or adjust the capital structure, the Group may adjust the amount of dividends paid to shareholders, return capital to shareholders, issue new shares or sell assets to reduce debt.

 

The capital risk management policy remains unchanged from the 30 June 2023 Annual Report.

 

Note 17 Equity - dividends

 


31-Dec-23

31-Dec-22


$'000

$'000

Final unfranked ordinary dividend (December 2023: 2.25 cents, December 2022: nil)

4,966

-

Franking credits

The franking credits available to the Group as at 31 December 2023 are estimated to be $338,000 (December 2022: $338,000).

 

Note 18 Fair value assessment

 

The fair value measurements used for all assets and liabilities held by the Group listed below are level 3:

 

Assets

31-Dec-23

30-Jun-23

Litigation funding assets

$'000

$'000

APAC

111,090

158,836

EMEA

279,923

232,574

Total Level 3 assets

391,014

391,410

Liabilities



Financial liabilities related to third-party interests in consolidated entities

244,726

243,990

Total Level 3 liabilities

244,726

243,990

 

Refer note 10 for movements in level 3 assets. There were no transfers into or out of level 3 during the period ended 31 December 2023.

 

Sensitivity of Level 3 Valuations

 

The Group's fair value policy provides for ranges of percentages to be applied against the risk adjustment factor to more than 159 discrete objective litigation events. The tables below set forth each of the key unobservable inputs used to value the Group's LFA assets and the applicable ranges and weighted average by relative fair value for such inputs.

 

31 December 2023

 

Item

Valuation technique

Unobservable Input

Min

Max

 

 

Litigation funding asset

Discounted cash flow

Discount rate

12.80%

12.80%





Duration (years)

0.08

5.01





Adjusted risk premium

0%

85%













Min

Max

 

 



Significant ruling or other objective event prior to trial court judgment

40%

80%





Trial court judgment or tribunal award

0%

85%





Appeal judgment

0%

85%





Settlement

70%

85%





Enforcement

75%

85%





Other

0%

45%



 

At each reporting period, the Group reviews the fair value of each litigation funding asset in connection with the preparation of the consolidated financial statements. A fair value of 10% higher or lower, while all other variables remain constant, in financial assets at fair value through profit or loss would have increased or decreased the Group's income and net assets by $39,101,000 as at 31 December 2023 (30 June 2023: $39,141,000). Similarly, a fair value of 10% higher or lower, while all other variables remain constant, in financial liabilities at fair value through profit or loss would have increased or decreased the Group's income and net assets by $24,473,000 as at 31 December 2023 (30 June 2023: $24,399,000).

 

Note 19 Contingent liabilities

 

The majority of the Group's funding agreements contain a contractual indemnity from the Group to the funded party that the Group will pay adverse costs awarded to the successful party in respect of costs incurred during the period of funding, should the client's litigation be unsuccessful. The Group's position is that for the majority of litigation projects which are subject to funding, the Group enters insurance arrangements which lessen or eliminate the impact of such awards and therefore any adverse costs order exposure.

 

Note 20 Third-party interests in consolidated entities

 

AASB 10 Consolidated Financial Statements requires the Group to consolidate fund investment vehicles over which it has exposure to variable returns from the fund investment vehicles. As a result, third party interests in relation to the Funds have been consolidated in the financial statements. 

 

As at 31 December 2023, the financial liability due to third-party interests is $244,726,000 (June 2023: $243,990,000), recorded at fair value as represented per Note 3. Amounts included in the consolidated statement of financial position represent the fair value of the third-party interests in the related financial assets and the amounts included in the consolidated statement of profit or loss and other comprehensive income represent the third-party share of any gain or loss during the period. Third-party interests exclude the 25% co-investment made by Litigation Capital Management Limited and its wholly owned subsidiaries ("LCM"). The third-party interests in the Funds carry an entitlement to receive an 8% soft return hurdle. Upon satisfaction of the third-party interests soft return hurdle, LCM is entitled to performance fees as fund manager on the basis of a deal by deal waterfall. The residual net cash flows are to be distributed 25% to LCM and 75% to the third-party interests until a IRR of 20% is achieved by the third-party interests, thereafter the net residual cash flows are distributed 35% to LCM and 65% to the third-party interests.

 

The following tables reflect the impact of consolidating the results of the Funds with the results for LCM to arrive at the totals reported in the consolidated statement of profit or loss and other comprehensive income, consolidated statement of financial position and consolidated statement of cash flows. The Fund column in the table below presents the interests of third-party investors comprising both the investment in the litigation funding assets made on their behalf and costs of administering the funds.  The LCM column includes the 25% co-investment in these litigation contracts.

 





Restated


31 December 2023

31 December 2022

Consolidated Statement of Comprehensive Income

LCM

Fund

Consolidated

LCM

Fund

Consolidated


$'000

$'000

$'000

$'000

$'000

$'000

Income





 


Gain on financial assets at fair value through profit or loss

21,586

30,843

52,429

7,140

11,339

18,479

Movement in financial liabilities related to third-party interests in consolidated entities

-

(30,546)

(30,546)

-

(8,409)

(8,409)

Total income from litigation assets

21,586

297

21,883

7,140

2,930

10,070








Interest income

331

91

421

5

-

5








Expenses







Employee benefits expense

(5,938)

-

(5,938)

(4,759)

-

(4,759)

Depreciation expense

(80)

-

(80)

(80)

-

(80)

Corporate expenses

(1,960)

-

(1,960)

(1,863)

(845)

(2,708)

Finance costs

(5,543)

-

(5,543)

(3,736)

(140)

(3,876)

Fund administration expense

(991)

(483)

(1,474)

(777)

(362)

(1,139)

Foreign currency gains/(losses)

1,530

95

1,625

267

(1,583)

(1,316)

Total expenses

(12,982)

(388)

(13,369)

(10,948)

(2,930)

(13,878)

Profit/(loss) before income tax expense

8,935

-

8,935

(3,803)

-

(3,803)






 


Analysed as:





 


Adjusted operating profit

15,998

-

15,998

1,324

-

1,324

Non-operating expenses

(1,520)

-

(1,520)

(1,391)

-

(1,391)

Finance costs

(5,543)

-

(5,543)

(3,736)

-

(3,736)

Profit/(loss) before income tax expense

8,935

-

8,935

(3,803)

-

(3,803)

Income tax expense

(1,642)

-

(1,642)

1,537

-

1,537

Profit/(loss) after income tax expense

7,293

-

7,293

(2,266)

-

(2,266)

 





 


Other comprehensive income for the period, net of tax

(101)

-

(101)

310

 

310

Total comprehensive income for the period

7,192

-

7,192

(1,956)

-

(1,956)

 


31 December 2023

30 June 2023

Consolidated statement of financial position

LCM

Fund

Consolidated

LCM

Fund

Consolidated

 

$'000

$'000

$'000

$'000

$'000

$'000

Assets

 






Cash and cash equivalents

70,251

17,450

87,701

82,973

21,484

104,457

Trade & other receivables

1,838

-

1,838

2,209

-

2,209

Due from resolution of financial assets

7,520

11,909

19,430

11,873

-

11,873

Financial assets at fair value through profit or loss

173,766

217,245

391,011

165,768

225,642

391,410

Contract costs

39,377

-

39,377

37,277

-

37,277

Property, plant and equipment

182

-

182

211

-

211

Intangible assets

333

-

333

356

-

356

Other assets

1,180

-

1,180

1,032

78

1,110

Total assets

294,447

246,604

541,051

301,699

247,204

548,903

Liabilities

 






Trade and other payables

3,511

1,879

5,390

4,321

3,214

7,535

Tax payable

7,770

-

7,770

7,769

-

7,769

Employee Benefits

988

-

988

906

-

906

Borrowings

59,783

-

59,783

68,976

-

68,976

Third-party interests in consolidated entities

-

244,726

244,726

-

243,990

243,990

Deferred tax liability

37,032

-

37,032

36,259

-

36,259

Total liabilities

109,085

246,604

355,689

118,231

247,204

365,435

Net assets

185,362

-

185,362

183,468

-

183,468

 

A financial liability at fair value through the income statement is recognised in the parent entity in relation to the transactions entered into with certain Fund structures to support the financing of LFAs. These arrangements fail the derecognition principles in IFRS 9 and represents the net share of the overall LFA at fair value apportioned to the Funds.

 






Restated



31 December 2023

31 December 2022

Consolidated Statement of Cash Flows

LCM

Fund

Consolidated

LCM

Fund

Consolidated


$'000

$'000

$'000

$'000

$'000

$'000








Cash flows from operating activities










 




Profit/(loss) after income tax expense for the period

7,293

-

7,293

(2,266)

-

(2,266)








Adjustments for:







Gain on financial assets at fair value through profit or loss

(21,586)

-

(21,586)

(7,140)

-

(7,140)

Depreciation and amortisation of intangibles

80

-

80

80

-

80

Share-based payments

463

-

463

308

-

308

Finance costs reclassified to financing activities

5,543

-

5,543

3,736

167

3,904

Income tax expense

1,642

-

1,642

(1,537)

-

(1,537)

Exceptional items

(144)

-

(144)

(39)

-

(39)

Fund costs reclassified to financing activities

991

-

991

777

-

777

Other, including foreign exchange rate movements

(1,122)

-

(1,122)

(842)

(5,045)

(5,887)








Change in operating assets and liabilities:







Proceeds from resolution of financial assets

33,214

38,950

72,164

20,082

1,722

21,804

Decrease/(increase) in trade and other receivables

608

-

608

(2,189)

-

(2,189)

(Funding) of financial assets

(15,187)

(16,345)

(31,531)

(18,520)

(31,579)

(50,099)

(Increase) in contract costs - litigation contracts

(2,305)

-

(2,305)

(2,938)

-

(2,938)

Decrease/(increase) in financial assets

780

-

780

432

-

432

(Decrease)/Increase in trade and other payables

(809)

(1,336)

(2,145)

109

(50)

59

(Decrease)/Increase in employee benefits

81

-

81

(22)

-

(22)

Income Tax paid

(868)

-

(868)

-

-

-

(Increase) in other assets

(161)

-

(161)

604

-

604

Net cash from/(used in) operating activities

8,515

21,270

29,785

(9,364)

(34,785)

(44,149)








Cash flows from investing activities







Payments for property, plant and equipment

(13)

-

(13)

(22)

-

(22)

Payments for intangibles

(15)

-

(15)

(34)

-

(34)

Refund/(payment) of security deposits

13

-

13

(12)

-

(12)

Net cash used in investing activities

(15)

-

(15)

(69)

-

(69)








Cash flows from financing activities







Payments for treasury shares

(796)

-

(796)

-

-

-

Dividends paid

(4,966)

-

(4,966)

-

-

-

Repayments of borrowings

(8,139)

-

(8,139)

-

(14,494)

(14,494)

Payments of finance costs

(5,752)

-

(5,752)

(3,350)

(132)

(3,482)

Payments of transaction costs related to third-party interests

(991)

-

(991)

(777)

-

(777)

Contributions from third-party interests in consolidated entities

-

11,010

11,010

-

45,298

45,298

Distributions to third-party interests in consolidated entities

-

(35,717)

(35,717)

-

-

-

Net cash (used in)/from financing activities

(20,644)

(24,707)

(45,351)

(4,127)

30,672

26,545

Net increase/(decrease) in cash and cash equivalents

(12,144)

(3,437)

(15,581)

(13,560)

(4,113)

(17,673)

Cash and cash equivalents at the beginning of the period

82,973

21,484

104,457

29,253

20,711

49,964

Effects of exchange rate changes on cash and cash equivalents

(578)

(597)

(1,175)

880

228

1,108

Cash and cash equivalents at the end of the period

70,251

17,450

87,701

16,573

16,826

33,399

 

Note 21 Earnings per share

 



31-Dec-23

31-Dec-22



$'000

$'000

Profit after income tax


7,293                                                

(2,266)

Profit after income tax attributable to the owners of Litigation Capital Management Limited

7,293                                                

(2,266)



 

 



Number

Number

Weighted average number of ordinary shares used in calculating basic earnings per share


106,606,481                                

106,613,927

Adjustments for calculation of diluted earnings per share:



 


Amounts uncalled on partly paid shares

1,309,066                                     

-


Options over ordinary shares

6,597,884                                      

-

Weighted average number of ordinary shares used in calculating diluted earnings per share

114,513,431                                

106,613,927



 

 



Cents

Cents

Basic earnings per share


6.84

(2.13)

Diluted earnings per share


6.37

(2.13)

 

Dilutive potential shares which are contingently issuable are only included in the calculation of diluted earnings per share where the conditions are met.

 

Note 22 Share-based payments

 

The share-based payment expense for the period was $463,000 (December 2022: $308,000).

 

Loan Funded Share Plans ('LSP')

 

As detailed in note 16, the Group has an equity scheme pursuant to which certain employees may access a LSP. The shares under LSP are issued at the exercise price by granting a limited recourse loan. The LSP shares are restricted until the loan is repaid. Options under this scheme can be granted without an underlying LSP share until they have been exercised and on this basis, do not form part of the Group's issued share capital. The underlying options have been accounted for as a share-based payments. The options are issued over a 1-3 year vesting period. Vesting conditions include satisfaction of customary continuous employment with the Group and may include a share price hurdle.

 

During the period the Group granted nil (December 2022: nil) shares under the LSP.

 

Set out below are summaries of shares/options granted under the LSP:

 

December 2023

 

Grant date

Expiry date

Exercise

Price

Balance at the start of the period

 Granted

 Exercised

 Expired/

forfeited/

other

Balance at the end of the period


04/12/2017

04/12/2027

$0.60

2,000,000




2,000,000


31/08/2018

31/08/2028

$0.77

411,972




411,972


19/11/2018

25/11/2028

$0.47

1,595,058




1,595,058


03/12/2018

03/12/2028

$0.89

100,000




100,000


01/11/2019

01/11/2029

£0.7394

1,432,753




1,432,753


13/10/2020

13/10/2030

£0.6655

616,520




616,520


27/10/2021

27/10/2031

£1.06

1,512,638




1,512,638


27/10/2021

27/10/2031

£1.06

99,037




99,037

1

27/10/2021

27/10/2031

£1.14

122,430




122,430

1




7,890,408

-

-

-

7,890,408


 

1 Options granted without an underlying LSP share until exercised ie, do not form part of the Group's issued share capital

 

 

Deferred Bonus Share Plan ('DBSP')

 

The Company has in place a DBSP. Options granted under the DBSP reflect past performance and are in the form of nil cost options and will vest in three equal tranches from the date of issue and are subject to continued employment over the three year period.

 

In addition, the Options granted under the DBSP are subject to malus and clawback provisions. In the event of a change of control of the Company, unvested awards will vest to the extent determined by the Board, taking into account the proportion of the period of time between grant and the normal vesting date that has elapsed at the date of the relevant event.

 

During the period the Group granted 771,911 (December 2022: 1,132,692) options under the DBSP.

 

Set out below are summaries of options granted under the DBSP:

 

December 23

 

Grant date

 Expiry date

 Exercise

Price

Balance at the start of the period

Granted

Exercised

Expired/

forfeited/

other

Balance at the end of the period

07/10/2022

07/10/2032

$0.00

1,132,692

-

(255,257)

-

877,435

04/10/2023

04/10/2033

$0.00

-

771,911

-

-

771,911




1,132,692

771,911

(255,257)

-

1,649,346

 

Executive Long Term Incentive Plan ('LTIP')

 

The Company has in place an Executive LTIP. Options over ordinary shares in the capital of the Company ("Ordinary Shares") are issued to recipients under the LTIP plan. The options set out above have been granted under the LTIP in the form of nil cost options and are subject to performance conditions which require the growth of Funds under Management ('FuM') over a five year performance period. The performance conditions associated with the options are set out below:

 

(1)  50% vesting on reaching a minimum of FuM of US$750m; and

(2)  100% vesting on reaching FuM of US$1bn.

 

 The vesting date of options granted is the later of:

(1)   the third anniversary of the Grant Date;

(2)   the satisfaction of the Performance Condition; or

(3)   the date of any adjustment under the Plan rules of the Plan at the Boards discretion.

 

Any awards made to the participants are subject to a five year holding period from the grant date. In the event of a change of control of the Company, unvested awards will vest to the extent determined by the Board, taking into account the proportion of the period of time between grant and the normal vesting date that has elapsed at the date of the relevant event and the extent to which any performance condition has been satisfied at the date of the relevant event.

 

During the period the Group granted nil (December 2022: 5,671,516) options under the LTIP.

 

Set out below are summaries of shares/options granted under the LTIP:

 

December 2023

 

Grant date

Expiry date

Exercise

Price

Balance at the start of the period

Granted

Exercised

Expired/

forfeited/

other

Balance at the end of the period

07/10/2022

07/10/2032

$0.0000

5,671,516

-

-

-

5,671,516




5,671,516

-

-

-

5,671,516

 

For the options under LSP granted during the current period, the valuation model inputs used in the Black-Scholes pricing model to determine the fair value at the grant date, are as follows:

 

Grant date

 Expiry dat

Share price at grant date

Exercise price

Expected volatility

Dividend yield

Risk-free interest rate

Fair value at grant date

1

04/10/2023

04/10/2033

£0.98

£0.00

35.00%

1.10%

3.79%

$1.820


1 AUD amount. GBP equivalent £0.952

 

The expected volatility reflects the assumption that the historical volatility over a period similar to the life of the options is indicative of future trends, which may not necessarily be the actual outcome.

 

Note 23 Events after the reporting period

 

In the Directors' opinion, no matter or circumstance has arisen since the end of the financial year, that has significantly affected, or may significantly affect, the operations of the Group, the results of those operations, or the state of affairs of the Group in future years.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings